273 related articles for article (PubMed ID: 19702115)
1. [Obesity and coronary heart disease: the mechanism of atherogenic impact].
Micić D; Polovina S
Med Pregl; 2009; 62 Suppl 3():43-6. PubMed ID: 19702115
[TBL] [Abstract][Full Text] [Related]
2. Adipokines: the missing link between insulin resistance and obesity.
Antuna-Puente B; Feve B; Fellahi S; Bastard JP
Diabetes Metab; 2008 Feb; 34(1):2-11. PubMed ID: 18093861
[TBL] [Abstract][Full Text] [Related]
3. Adipokines in diabetes and cardiovascular diseases.
Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
[TBL] [Abstract][Full Text] [Related]
4. Role of adipokines in complications related to obesity: a review.
Gnacińska M; Małgorzewicz S; Stojek M; Łysiak-Szydłowska W; Sworczak K
Adv Med Sci; 2009; 54(2):150-7. PubMed ID: 19875356
[TBL] [Abstract][Full Text] [Related]
5. [Adipokines: adiponectin, leptin, resistin and coronary heart disease risk].
Kopff B; Jegier A
Przegl Lek; 2005; 62 Suppl 3():69-72. PubMed ID: 16521924
[TBL] [Abstract][Full Text] [Related]
6. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
Tilg H; Moschen AR
Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
[TBL] [Abstract][Full Text] [Related]
7. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
Kieć-Klimczak M; Malczewska-Malec M; Huszno B
Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
[TBL] [Abstract][Full Text] [Related]
8. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
9. The endocrine function of adipose tissue: an update.
Ronti T; Lupattelli G; Mannarino E
Clin Endocrinol (Oxf); 2006 Apr; 64(4):355-65. PubMed ID: 16584505
[TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
11. [Obesity, inflammation and insulin resistance: which role for adipokines].
Antuna-Puente B; Feve B; Fellahi S; Bastard JP
Therapie; 2007; 62(4):285-92. PubMed ID: 17983554
[TBL] [Abstract][Full Text] [Related]
12. Obesity and cancer: the role of dysfunctional adipose tissue.
van Kruijsdijk RC; van der Wall E; Visseren FL
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2569-78. PubMed ID: 19755644
[TBL] [Abstract][Full Text] [Related]
13. Adipokines and etiopathology of metabolic disorders.
Al-Dokhi LM
Saudi Med J; 2009 Sep; 30(9):1123-32. PubMed ID: 19750255
[TBL] [Abstract][Full Text] [Related]
14. Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome.
Odrowaz-Sypniewska G
Adv Med Sci; 2007; 52():246-50. PubMed ID: 18217426
[TBL] [Abstract][Full Text] [Related]
15. Adipokines in liver diseases.
Marra F; Bertolani C
Hepatology; 2009 Sep; 50(3):957-69. PubMed ID: 19585655
[TBL] [Abstract][Full Text] [Related]
16. [Obesity and atherosclerosis].
Shimano H
Nihon Rinsho; 2009 Feb; 67(2):333-7. PubMed ID: 19202908
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?
Trayhurn P; Wang B; Wood IS
Br J Nutr; 2008 Aug; 100(2):227-35. PubMed ID: 18397542
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects associated with adipose tissue distribution.
Zahorska-Markiewicz B
Adv Med Sci; 2006; 51():111-4. PubMed ID: 17357288
[TBL] [Abstract][Full Text] [Related]
19. [Adipocytokines as mediators of metabolic role of adipose tissue].
Pandzić Jaksić V
Acta Med Croatica; 2010 Oct; 64(4):253-62. PubMed ID: 21688608
[TBL] [Abstract][Full Text] [Related]
20. Obesity in chronic kidney disease: good or bad?
Axelsson J
Blood Purif; 2008; 26(1):23-9. PubMed ID: 18182791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
